Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole

被引:15
作者
Rath, PM [1 ]
机构
[1] Univ Essen Gesamthsch, Inst Med Mikrobiol, D-45122 Essen, Germany
关键词
D O I
10.1093/jac/41.5.567
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibility testing of 27 Aspergillus reference stains belonging to five species was performed using the microdilution broth method with yeast nitrogen broth and RPMI-1640. Similar results were found using the two media. The strains of Aspergillus fumigatus (n = 8) and Aspergillus niger (n = 4) had MICs of amphotericin B in the range 0.125-0.5 mg/L. In contrast, nine out of 13 strains of Aspergillus flavus and Aspergillus nidulans had MICs in the range 2-16 mg/L. All strains had MICs of itraconazole in the range 0.03-0.5 mg/L. It is concluded that both media can be used for testing. Susceptibility testing to amphotericin B is recommended in clinical settings.
引用
收藏
页码:567 / 570
页数:4
相关论文
共 10 条
[1]  
BENNETT JE, 1995, PRINCIPLES PRACTICE, P2306
[2]   INVITRO SUSCEPTIBILITY AND SYNERGY STUDIES OF ASPERGILLUS SPECIES TO CONVENTIONAL AND NEW AGENTS [J].
DENNING, DW ;
HANSON, LH ;
PERLMAN, AM ;
STEVENS, DA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (01) :21-34
[3]   Itraconazole resistance in Aspergillus fumigatus [J].
Denning, DW ;
Venkateswarlu, K ;
Oakley, KL ;
Anderson, MJ ;
Manning, NJ ;
Stevens, DA ;
Warnock, DW ;
Kelly, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368
[4]   IN-VITRO SUSCEPTIBILITY OF FUNGAL ISOLATES OF CLINICALLY IMPORTANT SPECIMENS TO ITRACONAZOLE, FLUCONAZOLE AND AMPHOTERICIN-B [J].
DERMOUMI, H .
CHEMOTHERAPY, 1994, 40 (02) :92-98
[5]  
Espinel-Ingroff Ana, 1995, P1405
[6]   Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi [J].
EspinelIngroff, A ;
Bartlett, M ;
Bowden, R ;
Chin, NX ;
Cooper, C ;
Fothergill, A ;
McGinnis, MR ;
Menezes, P ;
Messer, SA ;
Nelson, PW ;
Odds, FC ;
Pasarell, L ;
Peter, J ;
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG ;
Shankland, GS ;
Walsh, TJ ;
Weitzman, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :139-143
[7]   IN-VITRO ACTIVITY OF THE NEW TRIAZOLE D0870 COMPARED WITH AMPHOTERICIN-B AND ITRACONAZOLE AGAINST ASPERGILLUS SPP [J].
MOORE, CB ;
LAW, D ;
DENNING, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (06) :831-836
[8]  
OTCENASEK M, 1992, ZBL BAKT-INT J MED M, V277, P100
[9]   Antifungal susceptibility testing: Technical advances and potential clinical applications [J].
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :776-784
[10]   COMPARISON OF AZOLES AGAINST ASPERGILLI INVITRO AND IN AN EXPERIMENTAL-MODEL OF PULMONARY ASPERGILLOSIS [J].
SCHMITT, HJ ;
EDWARDS, F ;
ANDRADE, J ;
NIKI, Y ;
ARMSTRONG, D .
CHEMOTHERAPY, 1992, 38 (02) :118-126